PANCREATICODUODENECTOMY

This adverse event was reported 664 times

These drugs are most commonly taken by patients reporting PANCREATICODUODENECTOMY:

# Drug Count
0 PANCRELIPASE 373
1 SITAGLIPTIN 137
2 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 45
3 EXENATIDE 30
4 INSULIN GLARGINE 24
5 METFORMIN 22
6 METFORMIN ER 500 MG 22
7 METFORMIN ER 750 MG 22
8 ASPIRIN 17
9 ASPIRIN 325 MG 17
See all common drugs associated with PANCREATICODUODENECTOMY

PANCREATICODUODENECTOMY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PANCRELIPASE 373 0.0094
1 PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE 2 0.0029
2 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 45 0.0021
3 SITAGLIPTIN 137 0.0019
4 PIOGLITAZONE AND METFORMIN HYDROCHLORIDE 1 0.0008
5 NATEGLINIDE 1 0.0007
6 BUFFERED ASPIRIN 1 0.0007
7 AZELASTINE HCL 1 0.0007
8 INFLIXIMAB-DYYB 2 0.0006
9 EXENATIDE 30 0.0006
See all drugs enriched for association with PANCREATICODUODENECTOMY

PANCREATICODUODENECTOMY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Glinide [EPC] 2 0.0002
1 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
2 Bismuth [EPC] 1 0.0002
3 Provitamin D2 Compound [EPC] 4 0.0001
4 Vitamin K [EPC] 1 0.0001
5 Insulin [EPC] 5 0.0001
6 Sulfonylurea [EPC] 12 0.0001
7 GLP-1 Receptor Agonist [EPC] 41 0.0001
8 Barbiturate [EPC] 1 0.0001
9 Insulin Analog [EPC] 37 0.0001
See all drug classes enriched for association with PANCREATICODUODENECTOMY